31 studies found for:    " July 20, 2011":" August 19, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Terminated Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment
Conditions: HIV Infection;   Tuberculosis
Interventions: Drug: Experimental: Empiric TB treatment;   Drug: ART only arm
22 Active, not recruiting Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth
Condition: HIV Prevention
Interventions: Behavioral: Integrated treatment program;   Behavioral: Treatment as Usual
23 Completed Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use
Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% vaginal gel;   Drug: Depo-medroxyprogesterone acetate (DMPA);   Drug: Oral contraceptive: LNG 150 mcg and EE 30 mcg
24 Active, not recruiting Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine (Vitamin B6)
25 Completed Vit D and HIV-Cardiovascular Disease in Children and Young Adults Vitamin D and HIV-CVD in Children and Young Adults
Condition: Vitamin D Deficiency
26 Recruiting Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events
Condition: HIV-Infection
Intervention: Other: Time of starting antiretroviral therapy
27 Completed
Has Results
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
Condition: HIV-1 Infection
Interventions: Drug: EFV/FTC/TDF;   Drug: Calcium Carbonate;   Drug: Vitamin D3;   Drug: Placebo for calcium carbonate;   Drug: Placebo for vitamin D3
28 Completed
Has Results
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
Condition: HIV-1 Infection
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: Tenofovir disoproxil fumarate;   Drug: Emtricitabine;   Drug: Placebo for Tenofovir disoproxil fumarate;   Drug: Placebo for Maraviroc;   Drug: Maraviroc
29 Completed Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults
Condition: Hepatitis c
Intervention: Behavioral: Leap-c group intervention
30 Recruiting History of the KSHV Inflammatory Cytokine Syndrome (KICS)
Conditions: KSHV Inflammatory Cytokine Syndrome (KICS);   KSHV;   HHV-8
31 Completed Preference Among 3 Female Condoms
Condition: Female Condom
Interventions: Device: Path Female Condom;   Device: FC2 female condom;   Device: Medtech female condom

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-31) Next Page   
Indicates status has not been verified in more than two years